Fig 2.

A 60-year-old woman's MR imaging post-subtotal resection with high edge contrast. The patient had a high survival estimation with PFS of 11.5 months and OS of 13.6 months. A, FLAIR prebevacizumab. B, T1 postcontrast prebevacizumab. C, FLAIR postbevacizumab. D, T1 postcontrast postbevacizumab. E, Overlay of the EC contour over the postbevacizumab FLAIR image. F, 3D presentation of the surface of the hyperintense region. Darker areas on the surface indicate lower EC and more indistinct border, whereas the lighter areas toward red show higher EC and more distinct border.